NASDAQ · Financial Statements
Applied Therapeutics, Inc. (APLT) Financial Statements
$0.10
NASDAQ: APLT
Market Cap $14.86M
Overview Financials Dividend Applied Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $-106.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024 Revenue $0 $0 $0 $10.0M $0 Operating Profit $-94.0M $-106.0M $-83.0M $-65.0M $-104.0M Net Profit $-94.0M $-106.0M $-83.0M $-120.0M $-106.0M EPS $-4.28 $-4.12 $-2.18 $-1.42 $-0.76 Op Margin — — — -645.8% -22922.9%
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024 Total Assets $105.0M $90.0M $38.0M $55.0M $87.0M Total Liabilities $23.0M $27.0M $34.0M $72.0M $30.0M Cash $57.0M $54.0M $17.0M $50.0M $79.0M Borrowings $3.0M $2.0M $2.0M $1.0M $3.0M
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024 Operating Cash Flow $-78.0M $-91.0M $-78.0M $-55.0M $-84.0M Investing Cash Flow $-19.0M $12.0M $13.0M $14.0M $0 Financing Cash Flow $3.0M $5.0M $3.0M $12.0M $9.0M Net Cash Flow $39.0M $-4.0M $-37.0M $33.0M $30.0M Free Cash Flow $-78.0M $-91.0M $-78.0M $-55.0M $-84.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.09 FCF Yield -453.33% Quick Ratio 0.96 Interest Coverage 0.00 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock